🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

24 recruiting trials

for Early Hepatocellular Carcinoma

Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC NCT06609876NA1 site📍 Beijing Sun Yat-sen University · Tests: Thermal ablation, Donafenib Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Breath Research Narrow Validation for Gastrointestinal Cancer Detection NCT07714538n/a6 sites📍 Maidstone📍 Liverpool📍 Glasgow Imperial College London Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma NCT06777628n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Immunochemotherapy combined with antiangiogenic FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer. NCT05095714NA1 site📍 Bondy Assistance Publique - Hôpitaux de Paris · Tests: Liver ultrasound and fast-MRI, Liver ultrasound The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling NCT06717295n/a4 sites📍 Rosario📍 Lagos📍 Cambridge Javier Toledo · Tests: DiNanoQ: A multi-cancer early detection (MCED) blood test, DiNanoTrack: Therapeutic Response Monitoring Blood Test A Study of Standard Of Care Versus Radio Ablation in Early Stage HCC NCT07628751NA2 sites📍 Waratah📍 Toronto University Health Network, Toronto · Tests: Stereotactic Ablative Body Radiotherapy (SABR), Therapies Early Detection of Liver Cancer by QUS NCT06345508n/a1 site📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Quantitative Ultrasound, B-mode Ultrasound, Magnetic Resonance Imaging, Liver Biopsy Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis NCT06822413n/a4 sites📍 Nanchang📍 Nanchang📍 Shanghai Second Affiliated Hospital, Zhejiang University, School of … · Tests: No Interventions AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR) NCT07062380n/a1 site📍 Wuhan Tongji Hospital · Tests: Curative liver resection, Real-world multimodal therapy Deep Liver Phenotyping and Immunology Study NCT04946773n/a1 site📍 Oxford University of Oxford Early-stage Detection of Liver Cancer by Proteins in Peripheral Blood NCT06544083n/a1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Proteomics Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC NCT06841172Phase 31 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: radiotherapy, Systemic therapy (Continuation of current first-line systemic therapy), Systemic therapy (Early switch to… The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients NCT07147335n/a1 site📍 Hengyang The First Affiliated Hospital of University of South China · Tests: serum AKR1B10 levels Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma NCT06652243EARLY Phase 11 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: SN301A Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study) NCT07265271n/a1 site📍 Duarte City of Hope Medical Center · Tests: Small RNA sequence, Rt-qPCR, Rt-qPCR Exploring the Value of Urine Proteomics-based Dynamic Surveillance for Early Recurrence After Radical Surgery for Hepatocellular Carcinoma: a Prospective Cohort Study NCT06861114n/a1 site📍 Guangzhou Zhujiang Hospital · Tests: Urine proteomics Prospective Cohort for Early Detection of Liver Cancer NCT05541601n/a1 site📍 Oxford University of Oxford · Tests: Blood and Urine samples The Detection of Small Early Liver Cancer With Natural History Follow up NCT05534906n/a1 site📍 Oxford University of Oxford · Tests: Blood & Urine Samples, Imaging Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642n/a3 sites📍 Phoenix📍 Jacksonville📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Tissue Collection Ate-Bev Early Response Prediction Model in Advanced HCC NCT05763277n/a1 site📍 Seoul Seoul National University Hospital · Tests: Early response evaluation Early Transjugular Intrahepatic Portosystemic Shunt for Advanced Hepatocellular Carcinoma NCT06624098NA2 sites📍 Beijing📍 Beijing Sun Yat-sen University · Tests: Early TIPS A Cohort Study (Risk Prediction of HCC in Patients With Chronic Liver Disease) NCT07820644n/a1 site📍 Shenzhen Cai Qingxian
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy